Watson's World
By Jesse Reynolds
| 10. 24. 2007
Nobel Prize season has come to an awkward end. Once a day during last week, we heard announcements of the winners in the six fields, including a high-profile award to Al Gore. The recipients will forever be honored to include the word "laureate" in their biographies.
But a few days later, the most prominent Nobel scientist winning scientist deeply marred his reputation. James Watson, who in 1962 won the prize for his elucidation of DNA's structure, unequivocally stated in an interview with the United Kingdom's Sunday Times that black people are less intelligent than whites. Speaking on development programs in Africa, Watson lamented that "all our social policies are based on the fact that their intelligence is the same as ours - whereas all the testing says not really… [P]eople who have to deal with black employees find [equality] is not true."
It may be tempting to dismiss this stunning utterance as the sloppy, irrelevant ramblings of a once-great scientist who is well past his prime. But Watson is a remarkably influential figure who has consistently reduced behavior to biology...
Related Articles
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...